Publications by authors named "Guangli Pang"

A type of quinoxaline-derived tridentate ,,-ligand was synthesized in good to excellent yields over three steps through iodination of 2-aryl indoles, sequential Kornblum-type oxidation with DMSO, and capture by 1,2-diaminobenzenes. The prepared atropisomeric ,,-ligand was successfully applied in the synthesis of -vinyl cinnamaldehyde nitrones as only -isomers in good yields through the Chan-Lam reaction. The method features an easily accessed tunable tridentate ,,-ligand, broad substrate scope, good functional group tolerance, and high -isomer for -vinyl nitrones.

View Article and Find Full Text PDF

A variety of oxazabicyclo[4.2.1]nonanone derivatives were prepared in good yields through a cinchonidine-catalyzed cascade reaction of -aryl-α,β-unsaturated nitrones and 1-ethynylnaphthalen-2-ols.

View Article and Find Full Text PDF

Alzheimer's disease (AD) is characterized by memory loss, intracellular neurofibrillary tangles, and extracellular plaque deposits composed of β-amyloid (Aβ). Previous reports showed that naturally occurring autoantibodies, such as intravenous immunoglobulin (IVIG), benefited patients with moderate-stage AD who carried an APOE-ε4 allele. However, the mechanism underlying the role of IVIG remains unclear.

View Article and Find Full Text PDF

Human serum albumin (HSA) is used as an important plasma volume expander in clinical practice. In the present study, HSA was N-terminally PEGylated and a PEGylated HAS (PEG-HSA) carrying one chain of PEG (20 kDa) per HSA molecule was obtained. The purity, secondary structure and hydrodynamic radius of the modified protein were characterized using sodium dodecyl sulfate polyacrylamide gel electrophoresis, circular dichroism measurements, and dynamic light scattering, respectively.

View Article and Find Full Text PDF
Article Synopsis
  • Human serum albumin (HSA) is commonly used in clinical settings as a plasma volume expander, but it can leak out into tissues and cause swelling due to increased capillary permeability during critical illnesses.
  • This study explores the idea of PEGylating HSA, which means attaching polyethylene glycol (PEG) to the protein to potentially reduce capillary leakage and increase its effectiveness.
  • Results indicate that PEGylated HSA has a significantly longer biological half-life, lower vascular permeability, and improved blood pressure recovery compared to regular HSA, making it a more suitable option for treating related illnesses.
View Article and Find Full Text PDF